Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc.

948 F.2d 1264
CourtCourt of Appeals for the Federal Circuit
DecidedDecember 26, 1991
Docket90-1328
StatusPublished
Cited by310 cases

This text of 948 F.2d 1264 (Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc., 948 F.2d 1264 (Fed. Cir. 1991).

Opinion

PAULINE NEWMAN, Circuit Judge.

Continental Can Company USA and Continental PET Technologies (collectively “Continental”) appeal the partial summary judgment of the United States District Court for the Southern District of Ohio, holding that United States Patent No. 4,108,324 (the Conobase or ’324 patent) is invalid. 1 Final judgment was entered on this issue, for the purpose of appeal.

Summary Judgment

An issue may be decided on motion for summary judgment when there is no genuine issue of material fact, and the movant is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(c); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986); Celotex Corp. v. Catrett, 477 U.S. 317, 325-26, 106 S.Ct. 2548, 2554, 91 L.Ed.2d 265 (1986); Scripps Clinic & Research Foundation v. Genentech, Inc., 927 F.2d 1565, 1571, 18 U.S.P.Q.2d 1001, 1005 (Fed.Cir.1991). The movant’s burden is to show that no fact material to the issue is in dispute, that even if all material factual inferences are drawn in favor of the non-movant the movant is entitled to judgment as a matter of law. Id. Summary judgment is as available in patent cases as in other areas of litigation. Chore-Time Equipment, Inc. v. Cumberland Corp., 713 F.2d 774, 778-79, 218 U.S.P.Q. 673, 675. (Fed.Cir.1983)

The purpose of the summary process is to avoid a clearly unnecessary trial, Matsushita Elec. Industrial Co. v. Zenith Radio Corp., 475 U.S. 574, 587, 106 S.Ct. 1348, 1356, 89 L.Ed.2d 538 (1986); it is not designed to substitute lawyers’ advocacy for evidence, or affidavits for examination before the fact-finder, when there is a genuine issue for trial. As stated in Adickes v. S.H. Kress & Co., 398 U.S. 144, 176, 90 S.Ct. 1598, 1618, 26 L.Ed.2d 142 (1970) (Black, J., concurring), “[t]he right to confront, cross-examine and impeach adverse witnesses is one of the most fundamental rights sought to be preserved by the Seventh Amendment”. See also Poller v. Columbia Broadcasting System, Inc., 368 U.S. 464, 473, 82 S.Ct. 486, 491, 7 L.Ed.2d 458 (1962).

While facilitating the disposition of legally meritless suits, when summary judg *1266 ment is improvidently granted the effect is to prolong litigation and increase its burdens. This is of particular concern in patent disputes, where the patent property is a wasting asset, and justice is ill served by delay in final resolution. In the case at bar, although some issues could be resolved on the law and undisputed facts, other issues require trial.

The Patented Invention

The ’824 patent, entitled “Ribbed Bottom Structure for Plastic Container”, inventors Suppayan M. Krishnakumar, Siegfried S. Roy, John F.E. Pocock, Salil K. Das, and Gautam K. Mahajan, is directed to a plastic bottle whose bottom structure has sufficient flexibility to impart improved impact resistance, combined with sufficient rigidity to resist deformation under internal pressure. The patented bottle is said to provide a superior combination of these properties. The bottom structure is illustrated as follows:

[[Image here]]

Claim 1 is the broadest claim of the ’324 patent:

1. A container having a sidewall and a bottom structure closing the container at an end portion of the sidewall,
the outer surface of the bottom structure comprising a central concavity,
a convex heel surrounding the concavity and merging therewith and with the sidewall end portion, the lowermost points of the heel lying in a common plane,
and a plurality of ribs interrupting the outer surface of the concavity and distributed in a symmetrical array,
each rib extending longitudinally in the direction of the heel and downwardly from an inner portion of the concavity, whereby the outer end portion of each rib is lower than the inner end portion thereof,
characterized by the feature that the ribs are hollow.

Claims 2 through 5 include additional limitations, described as contributing to the structure’s rigidity, flexibility, or both. Claim 2 specifies the ratios of thickness of the walls of the bottom structure to the thickness of the sidewall end portions. Claim 3 specifies that the margins of each rib merge smoothly with adjacent portions of the bottom structure. Claim 4 specifies that each rib is convex relative to the bottom structure. Claim 5 specifies that each rib is of fusiform (a gently tapered shape at the ends) configuration. Each claim carries an independent presumption of va *1267 lidity, 35 U.S.C. § 282, and stands or falls independent of the other claims. Altoona Publix Theatres, Inc. v. American Tri-Ergon Corp., 294 U.S. 477, 487, 55 S.Ct. 455, 459, 79 L.Ed. 1005 (1935).

Continental brought suit for patent infringement against Monsanto Company and Monsanto’s successor in this business, Hoover Universal, Inc. and Hoover’s parent company, Johnson Controls (collectively “Monsanto”). Monsanto moved for partial summary judgment based on issues of validity under 35 U.S.C. §§ 102 and 103.

I

35 U.S.C. § 102(a)

The statutory requirement that a patented invention be “new” is tested in accordance with 35 U.S.C. § 102(a), which provides that:

§ 102. A person shall be entitled to a patent unless—
(a) the invention was known or used by others in this country, or patented or described in a printed publication in this or a foreign country, before the invention thereof by the applicant for patent....

The district court found that all the claims of the ’324 patent were anticipated by U.S. Patent No. 3,468,443 (the Marcus patent).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Realtime Data, LLC v. Stanley
897 F. Supp. 2d 146 (S.D. New York, 2012)
Mitsubishi Chemical Corp. v. Barr Laboratories, Inc.
718 F. Supp. 2d 382 (S.D. New York, 2010)
Semiconductor Energy Laboratory Co. v. Samsung Electronics Co.
711 F. Supp. 2d 913 (W.D. Wisconsin, 2010)
NUANCE COMMUNICATIONS INC. v. Tellme Networks Inc.
707 F. Supp. 2d 472 (D. Delaware, 2010)
Alcon, Inc. v. TEVA PHARMACEUTICALS USA, INC.
664 F. Supp. 2d 443 (D. Delaware, 2009)
Avery Dennison Corp. v. Alien Technology Corp.
626 F. Supp. 2d 693 (N.D. Ohio, 2009)
Boston Scientific Corp. v. Johnson & Johnson
550 F. Supp. 2d 1102 (N.D. California, 2008)
Jackson v. Iris. Com
524 F. Supp. 2d 742 (E.D. Virginia, 2007)
The Coca-Cola Co. v. PEPSI-COLA CO
500 F. Supp. 2d 1364 (N.D. Georgia, 2007)
Kocinec v. Public Storage, Inc.
489 F. Supp. 2d 555 (E.D. Virginia, 2007)
Antanuos v. First Nat. Bank of Arizona
508 F. Supp. 2d 466 (E.D. Virginia, 2007)
Enzo Therapeutics, Inc. v. Yeda Research & Development Co.
477 F. Supp. 2d 699 (E.D. Virginia, 2007)
Zimmer Technology, Inc. v. Howmedica Osteonics Corp.
476 F. Supp. 2d 1024 (N.D. Indiana, 2007)
LUCENT TECHNOLOGIES INC. v. Gateway, Inc.
470 F. Supp. 2d 1163 (S.D. California, 2007)
LP MATTHEWS LLC v. Bath & Body Works, Inc.
458 F. Supp. 2d 198 (D. Delaware, 2006)
Diomed, Inc. v. AngioDynamics, Inc.
450 F. Supp. 2d 130 (D. Massachusetts, 2006)
Daiichi Pharmaceutical Co., Ltd. v. Apotex, Inc.
441 F. Supp. 2d 672 (D. New Jersey, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
948 F.2d 1264, Counsel Stack Legal Research, https://law.counselstack.com/opinion/continental-can-company-usa-inc-and-continental-pet-technologies-inc-v-cafc-1991.